TLR7 Recognition Is Dispensable for Influenza Virus A Infection but Important for the Induction of Hemagglutinin-Specific Antibodies in Response to the 2009 Pandemic Split Vaccine in Mice

被引:57
作者
Jeisy-Scott, Victoria [1 ,2 ]
Kim, Jin Hyang [1 ]
Davis, William G. [1 ]
Cao, Weiping [1 ]
Katz, Jacqueline M. [1 ]
Sambhara, Suryaprakash [1 ]
机构
[1] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[2] Emory Univ, Atlanta, GA 30322 USA
关键词
TOLL-LIKE RECEPTORS; B-CELL RESPONSES; IMMUNE-RESPONSES; IN-VITRO; IMMUNIZATION; ACTIVATION; REQUIRES; ANTIGENS; SIGNALS; SURFACE;
D O I
10.1128/JVI.01064-12
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recognition of pathogen-associated molecular patterns by pattern recognition receptors of the innate immune system is crucial for the initiation of innate and adaptive responses and for immunological memory. We investigated the role of TLR7 in the induction of adaptive immunity and long-term memory following influenza virus infection and vaccination in C57BL/6 mice. During infection with influenza A/PR8/34 virus, the absence of either TLR7 or MyD88 leads to reduced virus-specific antibodies in the serum and antibody-secreting cells in their secondary lymphoid organs, particularly in bone marrow. In spite of this, the absence of TLR7/MyD88 signaling did not impair the production of protective antibodies. Following immunization with the 2009 pandemic inactivated split vaccine, TLR7(-/-) mice had significantly lower levels of germinal center formation, antibody-secreting cells, and circulating influenza virus-specific antibodies than control animals. Consequently, TLR7(-/-) mice failed to develop protective immunological memory upon challenge. Furthermore, the immunogenicity of the split vaccine was likely due to TLR7 recognition of virion RNA, as its removal from the split vaccine significantly reduced the levels of influenza virus-specific antibodies and compromised the vaccine protective efficacy in mice. Taken together, our data demonstrate that TLR7 plays an important role in vaccine-induced humoral immune responses to influenza virus through the interaction with viral RNA present in the split vaccine.
引用
收藏
页码:10988 / 10998
页数:11
相关论文
共 64 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic [J].
Ahmed, Rafi ;
Oldstone, Michael B. A. ;
Palese, Peter .
NATURE IMMUNOLOGY, 2007, 8 (11) :1188-1193
[3]   The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults [J].
Ambrose, Christopher S. ;
Levin, Myron J. ;
Belshe, Robert B. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2011, 5 (02) :67-75
[4]  
[Anonymous], 2009, INFL SEAS FACT SHEET
[5]   Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways [J].
Barchet, W ;
Krug, A ;
Cella, M ;
Newby, C ;
Fischer, JAA ;
Dzionek, A ;
Pekosz, A ;
Colonna, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) :236-242
[6]   Toll-like receptors - sentries in the B-cell response [J].
Bekeredjian-Ding, Isabelle ;
Jego, Gaetan .
IMMUNOLOGY, 2009, 128 (03) :311-323
[7]   Live attenuated versus inactivated influenza vaccine in infants and young children [J].
Belshe, Robert B. ;
Edwards, Kathryn M. ;
Vesikari, Timo ;
Black, Steven V. ;
Walker, Robert E. ;
Hultquist, Micki ;
Kemble, George ;
Connor, Edward M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07) :685-696
[8]   Toll-Like Receptor Agonists Synergize with CD40L to Induce Either Proliferation or Plasma Cell Differentiation of Mouse B Cells [J].
Boeglin, Emmanuelle ;
Smulski, Cristian R. ;
Brun, Susana ;
Milosevic, Sara ;
Schneider, Pascal ;
Fournel, Sylvie .
PLOS ONE, 2011, 6 (10)
[9]   Toll-like Receptor 7 Controls the Anti-Retroviral Germinal Center Response [J].
Browne, Edward P. .
PLOS PATHOGENS, 2011, 7 (10)
[10]  
Cao WP, 2011, EXPERT REV VACCINES, V10, P1529, DOI [10.1586/erv.11.137, 10.1586/ERV.11.137]